# EDGAR Filing Document

**Accession Number:** 0000097134
**File Stem:** 0000097134-26-000015
**Filing Date:** 2026-5
**Character Count:** 110142
**Document Hash:** d786c8dc0c1201173f91e6d2f21c881a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000097134-26-000015.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0000097134-26-000015

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 91

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TENNANT CO
- **CENTRAL INDEX KEY:** 0000097134
- **STANDARD INDUSTRIAL CLASSIFICATION:** REFRIGERATION & SERVICE INDUSTRY MACHINERY [3580]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 410572550
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16191
- **FILM NUMBER:** 26942414

**BUSINESS ADDRESS:**
- **STREET 1:** 104000 CLEAN STREET
- **CITY:** EDEN PRAIRIE
- **STATE:** MN
- **ZIP:** 55344
- **BUSINESS PHONE:** 7635401200

**MAIL ADDRESS:**
- **STREET 1:** 104000 CLEAN STREET
- **CITY:** EDEN PRAIRIE
- **STATE:** MN
- **ZIP:** 55344

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TENNANT G H CO
- **DATE OF NAME CHANGE:** 19700515

?xml version='1.0' encoding='ASCII'? tnc-20260331

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

🗹 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2026

OR

□ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to __________

**Commission File Number 1-16191**

**__________________________________________**

![tennantcompanylogo.jpg](tnc-20260331_g1.jpg)

**TENNANT COMPANY**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Minnesota** | **41-0572550** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**10400 Clean Street** 

**Eden Prairie, Minnesota 55344**

(Address of principal executive offices)

(Zip Code)

**(763) 540-1200**

(Registrant's telephone number, including area code)

____________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.375 per share | TNC | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes <u>🗹</u> No <u>□</u>

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes <u>🗹</u> No <u>□</u>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | 🗹 | Accelerated filer | □ |
| Non-accelerated filer | □ | Smaller reporting company | □ |
| Emerging growth company | □ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 <u>□</u>

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes <u>□</u> No <u>🗹</u>

As of May 1, 2026, there were 17,038,903 shares of common stock outstanding.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| **[PART I - FINANCIAL INFORMATION](#i76015f54ee1c44899f4366fa9362c473_10) (Unaudited)** | **[PART I - FINANCIAL INFORMATION](#i76015f54ee1c44899f4366fa9362c473_10) (Unaudited)** | **Page** |
| [Item 1.](#i76015f54ee1c44899f4366fa9362c473_13) | <u>[Financial Statements](#i76015f54ee1c44899f4366fa9362c473_13)</u> | <u>[3](#i76015f54ee1c44899f4366fa9362c473_13)</u> |
|  | <u>[Consolidated Statements of Income](#i76015f54ee1c44899f4366fa9362c473_16)</u> | <u>[3](#i76015f54ee1c44899f4366fa9362c473_16)</u> |
|  | <u>[Consolidated Statements of Comprehensive Income](#i76015f54ee1c44899f4366fa9362c473_19)</u> | <u>[4](#i76015f54ee1c44899f4366fa9362c473_19)</u> |
|  | <u>[Consolidated Balance Sheets](#i76015f54ee1c44899f4366fa9362c473_22)</u> | <u>[5](#i76015f54ee1c44899f4366fa9362c473_22)</u> |
|  | <u>[Consolidated Statements of Cash Flows](#i76015f54ee1c44899f4366fa9362c473_25)</u> | <u>[6](#i76015f54ee1c44899f4366fa9362c473_25)</u> |
|  | <u>[Consolidated Statements of Equity](#i76015f54ee1c44899f4366fa9362c473_28)</u> | <u>[8](#i76015f54ee1c44899f4366fa9362c473_28)</u> |
|  | <u>[Notes to Consolidated Financial Statements](#i76015f54ee1c44899f4366fa9362c473_31)</u> | <u>[9](#i76015f54ee1c44899f4366fa9362c473_31)</u> |
| [Item 2.](#i76015f54ee1c44899f4366fa9362c473_88) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i76015f54ee1c44899f4366fa9362c473_88)</u> | <u>[26](#i76015f54ee1c44899f4366fa9362c473_88)</u> |
| [Item 3.](#i76015f54ee1c44899f4366fa9362c473_127) | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i76015f54ee1c44899f4366fa9362c473_127)</u> | <u>[32](#i76015f54ee1c44899f4366fa9362c473_127)</u> |
| [Item 4.](#i76015f54ee1c44899f4366fa9362c473_130) | <u>[Controls and Procedures](#i76015f54ee1c44899f4366fa9362c473_130)</u> | <u>[32](#i76015f54ee1c44899f4366fa9362c473_130)</u> |
| **[PART II - OTHER INFORMATION](#i76015f54ee1c44899f4366fa9362c473_133)** | **[PART II - OTHER INFORMATION](#i76015f54ee1c44899f4366fa9362c473_133)** |  |
| [Item 1.](#i76015f54ee1c44899f4366fa9362c473_136) | <u>[Legal Proceedings](#i76015f54ee1c44899f4366fa9362c473_136)</u> | <u>[32](#i76015f54ee1c44899f4366fa9362c473_136)</u> |
| [Item 1A.](#i76015f54ee1c44899f4366fa9362c473_139) | <u>[Risk Factors](#i76015f54ee1c44899f4366fa9362c473_139)</u> | <u>[32](#i76015f54ee1c44899f4366fa9362c473_139)</u> |
| [Item 2.](#i76015f54ee1c44899f4366fa9362c473_142) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i76015f54ee1c44899f4366fa9362c473_142)</u> | <u>[33](#i76015f54ee1c44899f4366fa9362c473_142)</u> |
| Item 5. | <u>[Other Information](#i76015f54ee1c44899f4366fa9362c473_145)</u> | <u>[32](#i76015f54ee1c44899f4366fa9362c473_145)</u> |
| [Item 6.](#i76015f54ee1c44899f4366fa9362c473_151) | <u>[Exhibits](#i76015f54ee1c44899f4366fa9362c473_151)</u> | <u>[34](#i76015f54ee1c44899f4366fa9362c473_151)</u> |
| <u>[Signatures](#i76015f54ee1c44899f4366fa9362c473_154)</u> |  | <u>[35](#i76015f54ee1c44899f4366fa9362c473_154)</u> |

---

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**PART I** – **FINANCIAL INFORMATION**

**<u>Item 1.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Financial Statements</u>**

**TENNANT COMPANY**

**CONSOLIDATED STATEMENTS OF INCOME**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| *(In millions, except shares and per share data)* | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
|  | **2026** | **2025** |
| Net sales | $297.9 | $290.0 |
| Cost of sales | 184.3 | 170.0 |
| &nbsp;&nbsp;&nbsp;Gross profit | 113.6 | 120.0 |
| Selling and administrative expense | 98.1 | 90.7 |
| Research and development expense | 10.6 | 9.7 |
| &nbsp;&nbsp;&nbsp;Operating income | 4.9 | 19.6 |
| Interest expense, net | (3.4) | (2.3) |
| Net foreign currency transaction loss | (0.4) | (0.2) |
| Other (expense) income, net | (0.2) | 0.1 |
| &nbsp;&nbsp;&nbsp;Income before income taxes | 0.9 | 17.2 |
| Income tax expense | 0.7 | 4.1 |
| Net income | $0.2 | $13.1 |
| Net income per share |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.01 | $0.70 |
| &nbsp;&nbsp;&nbsp;Diluted | $0.01 | $0.69 |
| Weighted average shares outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 17558556 | 18702438 |
| &nbsp;&nbsp;&nbsp;Diluted | 17804603 | 18960007 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TENNANT COMPANY**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| *(In millions)* | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
|  | **2026** | **2025** |
| Net income | $0.2 | $13.1 |
| Other comprehensive (loss) income: |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments (net of related tax (expense) benefit of $(0.3) and $0.2, respectively) | (4.8) | 15.5 |
| &nbsp;&nbsp;&nbsp;Pension and postretirement medical benefits (net of related tax expense of $0 and $0, respectively) |  | (0.1) |
| &nbsp;&nbsp;&nbsp;Derivative financial instruments (net of related tax (expense) benefit of $(0.2) and $0.0, respectively) | 0.7 | (0.1) |
| Total other comprehensive (loss) income, net of tax | (4.1) | 15.3 |
| Total comprehensive (loss) income including noncontrolling interest | (3.9) | 28.4 |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments attributable to noncontrolling interest |  | 0.4 |
| Comprehensive (loss) income attributable to Tennant Company | $(3.9) | $28.0 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TENNANT COMPANY**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| | **(Unaudited)** | |
| *(In millions, except shares and per share data)* | **March 31,<br>2026** | **December 31,<br>2025** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $82.6 | $106.4 |
| &nbsp;&nbsp;&nbsp;Receivables, less allowances of $10.5 and $10.4, respectively | 280.6 | 256.8 |
| &nbsp;&nbsp;&nbsp;Inventories | 204.6 | 198.5 |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | 43.3 | 38.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 611.1 | 599.7 |
| &nbsp;&nbsp;&nbsp;Property, plant and equipment, less accumulated depreciation of $297.1 and $289.0, respectively | 185.4 | 189.8 |
| &nbsp;&nbsp;&nbsp;Operating lease assets | 55.6 | 56.9 |
| &nbsp;&nbsp;&nbsp;Goodwill | 209.9 | 208.6 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | 52.5 | 52.6 |
| &nbsp;&nbsp;&nbsp;Other assets | 162.1 | 161.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1276.6 | $1268.9 |
| **LIABILITIES AND EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | $0.4 | $0.4 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 123.1 | 127.5 |
| &nbsp;&nbsp;&nbsp;Employee compensation and benefits | 39.6 | 40.9 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 125.5 | 124.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 288.6 | 293.1 |
| &nbsp;&nbsp;&nbsp;Long-term debt | 358.3 | 273.2 |
| &nbsp;&nbsp;&nbsp;Long-term operating lease liabilities | 33.8 | 35.5 |
| &nbsp;&nbsp;&nbsp;Employee benefits | 15.4 | 15.7 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 4.2 | 3.3 |
| &nbsp;&nbsp;&nbsp;Other liabilities | 43.3 | 44.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 455.0 | 372.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $743.6 | $665.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commitments and contingencies (Note 13) |  |  |
| Common Stock, $0.375 par value; 60,000,000 shares authorized; 17,037,788 and 17,846,681 shares issued and outstanding, respectively | 6.4 | 6.7 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital |  |  |
| &nbsp;&nbsp;&nbsp;Retained earnings | 562.1 | 628.1 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (37.3) | (33.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Tennant Company shareholders' equity | 531.2 | 601.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest | 1.8 | 1.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 533.0 | 603.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and total equity | $1276.6 | $1268.9 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TENNANT COMPANY**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| *(In millions)* | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
|  | **2026** | **2025** |
| **OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;Net income | $0.2 | $13.1 |
| &nbsp;&nbsp;Adjustments to reconcile net income to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 11.4 | 10.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 3.5 | 3.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax benefit | 3.3 | 0.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 1.5 | 3.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bad debt and returns expense | 0.5 | 0.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 0.1 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables | (25.2) | 10.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (11.7) | (8.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (2.5) | (8.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee compensation and benefits | (2.1) | (14.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | (10.2) | (11.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in operating activities | (31.2) | (0.4) |
| **INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;Purchases of property, plant and equipment | (3.2) | (7.0) |
| &nbsp;&nbsp;Payments made in connection with business acquisition, net of cash acquired | (7.2) |  |
| &nbsp;&nbsp;Investment in leased assets | (0.1) | (0.1) |
| &nbsp;&nbsp;Cash received from leased assets | 0.2 | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (10.3) | (6.9) |
| **FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;Proceeds from borrowings | 105.0 | 15.0 |
| &nbsp;&nbsp;Repayments of borrowings | (20.0) | (0.8) |
| &nbsp;&nbsp;Repurchases from exercise of stock options, net of employee tax withholdings obligations of $2.9 and $2.6, respectively | (2.3) | (2.1) |
| &nbsp;&nbsp;Repurchases of common stock | (60.0) | (20.2) |
| &nbsp;&nbsp;Dividends paid | (5.5) | (5.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 17.2 | (13.7) |
| Effect of exchange rate changes on cash and cash equivalents | 0.5 | 0.7 |
| **Net decrease in cash and cash equivalents** | (23.8) | (20.3) |
| Cash and cash equivalents at beginning of period | 106.4 | 99.8 |
| **Cash and cash equivalents at end of period** | $82.6 | $79.5 |

---

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

---

| | | |
|:---|:---|:---|
| **SUPPLEMENTAL CASH FLOW INFORMATION** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| *(In millions)* | **2026** | **2025** |
| &nbsp;&nbsp;&nbsp;Cash (received) paid for income taxes | $(1.9) | $3.5 |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | 4.1 | 2.9 |
| &nbsp;&nbsp;&nbsp;Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from operating leases | 6.7 | 5.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financing cash flows from financing leases | 0.1 |  |
| &nbsp;&nbsp;&nbsp;Lease assets obtained in exchange for new operating lease liabilities | 4.2 | 4.0 |
| &nbsp;&nbsp;&nbsp;Lease assets obtained in exchange for new financing lease liabilities | 0.2 | 0.1 |
| Supplemental non-cash investing and financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures in accounts payable | 1.5 | 1.6 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TENNANT COMPANY**

**CONSOLIDATED STATEMENTS OF EQUITY**

**(Unaudited)**

*(In millions, except shares and per share data)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | | |
| | **Common <br>Shares** | **Common<br>Stock** | **Additional<br>Paid-in<br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Tennant<br>Company<br>Shareholders'<br>Equity** |<br>**Noncontrolling<br>Interest** |<br>**Total Equity** |
| Balance, December 31, 2025 | 17846681 | $6.7 | $— | $628.1 | $(33.2) | $601.6 | $1.8 | $603.4 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  | 0.2 |  | 0.2 |  | 0.2 |
| &nbsp;&nbsp;&nbsp;Other comprehensive loss |  |  |  |  | (4.1) | (4.1) |  | (4.1) |
| &nbsp;&nbsp;&nbsp;Issue stock for directors, employee benefit and stock plans, net of related tax withholdings of 46,646 shares | 140877 |  | (2.3) |  |  | (2.3) |  | (2.3) |
| &nbsp;&nbsp;&nbsp;Share-based compensation |  |  | 1.5 |  |  | 1.5 |  | 1.5 |
| &nbsp;&nbsp;&nbsp;Repurchases of common stock, including excise tax | (949770) | (0.3) | 0.8 | (60.5) |  | (60.0) |  | (60.0) |
| &nbsp;&nbsp;&nbsp;Dividends paid $0.310 per common share |  |  |  | (5.5) |  | (5.5) |  | (5.5) |
| &nbsp;&nbsp;&nbsp;Other |  |  |  | (0.2) |  | (0.2) |  | (0.2) |
| Balance, March 31, 2026 | 17037788 | $6.4 | $— | $562.1 | $(37.3) | $531.2 | $1.8 | $533.0 |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | **Tennant Company Shareholders** | | |
| | **Common<br>Shares** | **Common<br>Stock** | **Additional<br>Paid-in <br>Capital** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Tennant<br>Company<br>Shareholders'<br>Equity** |<br>**Noncontrolling<br>Interest** |<br>**Total Equity** |
| Balance, December 31, 2024 | 18849456 | $7.1 | $76.7 | $609.7 | $(72.7) | $620.8 | $1.3 | $622.1 |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  | 13.1 |  | 13.1 |  | 13.1 |
| &nbsp;&nbsp;&nbsp;Other comprehensive income |  |  |  |  | 15.3 | 15.3 |  | 15.3 |
| &nbsp;&nbsp;&nbsp;Issue stock for directors, employee benefit and stock plans, net of related tax withholdings of 29,497 shares | 89695 | (0.1) | (2.1) |  |  | (2.2) |  | (2.2) |
| &nbsp;&nbsp;&nbsp;Share-based compensation |  |  | 3.2 |  |  | 3.2 |  | 3.2 |
| &nbsp;&nbsp;&nbsp;Repurchases of common stock, including excise tax | (235866) |  | (20.2) |  |  | (20.2) |  | (20.2) |
| &nbsp;&nbsp;&nbsp;Dividends paid $0.295 per common share |  |  |  | (5.6) |  | (5.6) |  | (5.6) |
| &nbsp;&nbsp;&nbsp;Other |  |  |  |  |  |  | 0.4 | 0.4 |
| Balance, March 31, 2025 | 18703285 | $7.0 | $57.6 | $617.2 | $(57.4) | $624.4 | $1.7 | $626.1 |

---

See accompanying notes to consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**TENNANT COMPANY**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**(In millions, except shares and per share data)**

**1.&nbsp;&nbsp;&nbsp;&nbsp;Nature of Business**

Tennant Company ("the Company", "we", "us", or "our") is a world leader in designing, manufacturing and marketing solutions that help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions.

Our products are used in many types of environments, including factories and warehouses, distribution centers, office buildings, public venues such as arenas and stadiums, schools and universities, hospitals and clinics, and more.

Customers include contract cleaners to whom organizations outsource facilities maintenance as well as businesses that perform facilities maintenance themselves. The Company reaches these customers through the industry's largest direct sales and service organization and through a strong and well-supported network of authorized distributors worldwide.

**2.&nbsp;&nbsp;&nbsp;&nbsp;Significant Accounting Policies**

*Basis of Presentation* – The accompanying unaudited consolidated financial statements have been prepared in accordance with the U.S. Securities and Exchange Commission ("SEC") requirements for interim reporting. In our opinion, the consolidated financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary for the fair presentation of our financial position and results of operations.

These statements should be read in conjunction with the consolidated financial statements and notes included in our annual report on Form 10-K for the year ended December 31, 2025. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

There are no newly adopted accounting pronouncements during the three months ended March 31, 2026 that impacted the Company.

**3.&nbsp;&nbsp;&nbsp;&nbsp;Revenue**

***Disaggregation of Revenue***

The following tables illustrate the disaggregation of revenue by geographic area, groups of similar products and services and sales channels:

*Net sales by geographic area*

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Americas | $194.0 | $197.3 |
| Europe, Middle East and Africa | 86.9 | 76.0 |
| Asia Pacific | 17.0 | 16.7 |
| Total | $297.9 | $290.0 |

---

Net sales are attributed to each geographic area based on the end-user country and are net of intercompany sales.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

*Net sales by groups of similar products and services*

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Equipment | $178.1 | $172.8 |
| Parts and consumables | 64.6 | 67.3 |
| Service and other | 55.2 | 49.9 |
| Total | $297.9 | $290.0 |

---

*Net sales by sales channel*

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Sales direct to consumer | $210.2 | $205.1 |
| Sales to distributors | 87.7 | 84.9 |
| Total | $297.9 | $290.0 |

---

***Contract Liabilities***

*Sales Returns*

The right of return may exist explicitly or implicitly with our customers. When the right of return exists, we adjust the transaction price for the estimated effect of returns. We estimate the expected returns using the expected value method by assessing historical sales levels and the timing and magnitude of historical sales return levels as a percent of sales and projecting this experience into the future.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

*Sales Incentives*

Our sales contracts may contain various customer incentives, such as volume-based rebates or other promotions. We reduce the transaction price for certain customer programs and incentive offerings that represent variable consideration. Sales incentives given to our customers are recorded using the most likely amount approach for estimating the amount of consideration to which the Company will be entitled. We forecast the most likely amount of the incentive to be paid at the time of sale, update this forecast quarterly, and adjust the transaction price accordingly to reflect the new amount of incentives expected to be earned by the customer. A majority of our customer incentives are settled within one year. We record our accruals for volume-based rebates and other promotions in other current liabilities on our consolidated balance sheets.

The change in our sales incentive accrual balance was as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Beginning balance | $14.8 | $16.1 |
| &nbsp;&nbsp;&nbsp;Additions to sales incentive accrual | 5.8 | 5.7 |
| &nbsp;&nbsp;&nbsp;Contract payments | (9.9) | (7.9) |
| &nbsp;&nbsp;&nbsp;Foreign currency fluctuations | (0.1) | (0.3) |
| Ending balance | $10.6 | $13.6 |

---

*Deferred Revenue*

Deferred revenue represents consideration received or billed in advance of satisfying performance obligations that are recognized over time.

Our deferred revenue balance primarily consists of (i) amounts related to autonomous robotic machine ("AMR") arrangements that are recognized over time and (ii) prepaid service and maintenance contracts for our machines. Service and maintenance contracts generally provide routine maintenance, parts coverage, and support services and are recognized ratably over the contractual service period, which typically ranges from 12 months to 60 months.

Prior to March 1, 2026, certain AMR customer arrangements required an active autonomy subscription for customers to benefit from autonomous functionality. Amounts allocated to these subscription-based arrangements were recognized over the contractual subscription period and included in deferred revenue. Effective March 1, 2026, the Company amended its AMR arrangements such that customers receive full rights to the embedded autonomy software upon delivery of the machine along with ongoing connectivity services. Revenue associated with the embedded autonomy software is recognized at the time of sale. Revenue related to connectivity services (which include cloud connectivity, software updates, diagnostic, monitoring and support services) is recognized on a straight line basis over the period the services are made available.

In arrangements that include multiple performance obligations, the transaction price is allocated to each performance obligation based on relative standalone selling prices.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

The change in the deferred revenue balance was as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Beginning balance | $32.4 | $20.6 |
| &nbsp;&nbsp;&nbsp;Increase in deferred revenue representing our obligation to satisfy future performance obligations | 8.3 | 5.7 |
| &nbsp;&nbsp;&nbsp;Decrease in deferred revenue for amounts recognized in net sales for satisfied performance obligations | (6.2) | (3.9) |
| &nbsp;&nbsp;&nbsp;Foreign currency fluctuations | (0.1) | 0.1 |
| Ending balance | $34.4 | $22.5 |

---

As of March 31, 2026, $16.9 million and $17.5 million of deferred revenue was reported in other current liabilities and other liabilities, respectively, on our consolidated balance sheets. Of these amounts, we expect to recognize the following approximate amounts in net sales in the following periods:

---

| | |
|:---|:---|
| Remaining 2026 | $14.6 |
| 2027 | 8.3 |
| 2028 | 5.8 |
| 2029 | 3.9 |
| 2030 | 1.7 |
| Thereafter | 0.1 |
| Total | $34.4 |

---

As of December 31, 2025, $16.6 million and $15.8 million of deferred revenue was reported in other current liabilities and other liabilities, respectively, on our consolidated balance sheets.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**4.&nbsp;&nbsp;&nbsp;&nbsp;Management Actions** 

*Restructuring Actions*

During the three months ended March 31, 2026, we incurred restructuring expenses as part of our ongoing global reorganization efforts. The following pre-tax restructuring charges were included in selling and administrative expense in the consolidated statements of income.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Severance-related costs | $0.3 | $1.5 |
| Total pre-tax restructuring costs | $0.3 | $1.5 |

---

Our restructuring actions represent the execution of a multi-year enterprise strategy to drive increased productivity throughout our operations. The charges in 2026 and 2025 impacted all operating segments and were related to a global workforce realignment to support our key strategic initiatives.

A reconciliation of the beginning and ending liability balances for severance-related costs is as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Beginning balance | $7.4 | $8.6 |
| New charges | 1.0 | 1.7 |
| Cash payments | (2.5) | (3.0) |
| Foreign currency fluctuations | (0.1) | 0.2 |
| Adjustments to accrual | (0.7) | (0.2) |
| Ending balance | $5.1 | $7.3 |

---

**5.&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions**

*Clean Machine*

On February 2, 2026, we acquired 100% of Clean Machine Falkenberg AB and Repax AB (collectively, "Clean Machine"), as we continue to expand our footprint in the EMEA region. The total purchase price was $7.7 million. The financial results for Clean Machine have been included in our consolidated financial statements since the acquisition date. The acquisition was not material to our consolidated financial statements.

*R4Y*

On September 1, 2025, we acquired 100% of Reinigungstechnik 4 You GmbH ("R4Y"), as we continue to expand our footprint in the EMEA region. The total purchase price was $3.6 million. The financial results for R4Y have been included in our consolidated financial statements since the acquisition date. The acquisition was not material to our consolidated financial statements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**6.&nbsp;&nbsp;&nbsp;&nbsp;Inventories**

Inventories are valued at the lower of cost or net realizable value and consisted of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Inventories carried at LIFO: |  |  |
| &nbsp;&nbsp;Finished goods<sup>(a)</sup> | $91.4 | $85.0 |
| &nbsp;&nbsp;Raw materials and work-in-process | 32.6 | 35.5 |
| &nbsp;&nbsp;Excess of FIFO over LIFO cost<sup>(b)</sup> | (59.6) | (54.9) |
| Total LIFO inventories | $64.4 | $65.6 |
| Inventories carried at FIFO: |  |  |
| &nbsp;&nbsp;Finished goods<sup>(a)</sup> | $69.3 | $64.3 |
| &nbsp;&nbsp;Raw materials and work-in-process | 70.9 | 68.6 |
| Total FIFO inventories | $140.2 | $132.9 |
| Total inventories | $204.6 | $198.5 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Finished goods include machines, parts and consumables and component parts that are used in our products.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The difference between replacement cost and the stated LIFO inventory value is not materially different from the reserve for the LIFO valuation method.

**7.&nbsp;&nbsp;&nbsp;&nbsp;Goodwill and Intangible Assets**

The changes in the carrying amount of goodwill for the three months ended March 31, 2026 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Goodwill** | **Accumulated**<br>**Impairment**<br>**Losses** | **Total** |
| Balance as of December 31, 2025 | $243.9 | $(35.3) | $208.6 |
| &nbsp;&nbsp;Additions | 3.7 |  | 3.7 |
| &nbsp;&nbsp;Foreign currency fluctuations | (3.0) | 0.6 | (2.4) |
| Balance as of March 31, 2026 | $244.6 | $(34.7) | $209.9 |

---

The balances of acquired intangible assets, excluding goodwill, were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Customer Lists** | **Trade Names** | **Technology** | **Total** |
| Balance as of March 31, 2026 |  |  |  |  |
| &nbsp;&nbsp;Original cost | $176.3 | $30.7 | $16.8 | $223.8 |
| &nbsp;&nbsp;Accumulated amortization | (128.9) | (26.9) | (15.5) | (171.3) |
| Carrying value | $47.4 | $3.8 | $1.3 | $52.5 |
| Weighted average original life (in years) | 14 | 10 | 12 |  |
| Balance as of December 31, 2025 |  |  |  |  |
| &nbsp;&nbsp;Original cost | $174.9 | $31.1 | $16.7 | $222.7 |
| &nbsp;&nbsp;Accumulated amortization | (128.1) | (26.6) | (15.4) | (170.1) |
| Carrying value | $46.8 | $4.5 | $1.3 | $52.6 |
| Weighted average original life (in years) | 14 | 10 | 12 |  |

---

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

Amortization expense on intangible assets for the three months ended March 31, 2026 and 2025 was $3.5 million and $3.4 million, respectively.

Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for each of the five succeeding years and thereafter is as follows:

---

| | |
|:---|:---|
| Remaining 2026 | $9.7 |
| 2027 | 9.2 |
| 2028 | 7.3 |
| 2029 | 6.7 |
| 2030 | 6.1 |
| Thereafter | 13.5 |
| Total | $52.5 |

---

**8.&nbsp;&nbsp;&nbsp;&nbsp;Debt**

On August 7, 2024, we and certain of our foreign subsidiaries entered into an Amended and Restated Credit Agreement (the "2024 Credit Agreement"), which amends and restates the Amended and Restated Credit Agreement, dated April 5, 2021, as amended on November 10, 2022. The 2024 Credit Agreement provides us and certain of our foreign subsidiaries access to a senior secured credit facility until August 7, 2029, consisting of a revolving facility in an amount up to $650.0 million, with an option to expand the revolving facility or obtain incremental term loans by up to $325.0 million, with the consent of the lenders willing to provide additional borrowings in the form of increases to their revolving facility commitment or funding of incremental term loans. Borrowings may be denominated in U.S. dollars or certain other currencies.

The fee for undrawn committed funds under the revolving facility of the 2024 Credit Agreement ranges from an annual rate of 0.15% to 0.30%, depending on our leverage ratio. Borrowings denominated in U.S. dollars under the 2024 Credit Agreement bear interest at a rate per annum equal to (a) the greatest of (i) the prime rate, (ii) the NYFRB Rate (as defined in the 2024 Credit Agreement) plus 0.50% and (iii) the Adjusted Term SOFR Rate (as defined in the 2024 Credit Agreement) for a one month period plus 1%; but in any case not less than 1%, plus an additional spread of 0.25% to 1%, depending on our leverage ratio, (b) the Adjusted Term SOFR Rate plus an additional spread of 1.25% to 2%, depending on our leverage ratio, or (c) the Adjusted Daily Simple RFR (as defined in the 2024 Credit Agreement) plus an additional spread of 1.25% to 2%, depending on our leverage ratio.

In connection with the 2024 Credit Agreement, we reaffirmed our security interest in favor of the lenders in substantially all its personal property and pledged the stock of certain of its domestic and foreign subsidiaries. The obligations under the 2024 Credit Agreement are also guaranteed by certain of the Company's subsidiaries and those subsidiaries also provided a security interest in their similar personal property.

The 2024 Credit Agreement contains customary representations, warranties and covenants, including but not limited to covenants restricting the Company's ability to incur indebtedness and liens and merge or consolidate with another entity. Further, the 2024 Credit Agreement contains the following covenants:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a covenant requiring us to maintain an indebtedness to EBITDA ratio, determined as of the end of each of its fiscal quarters, of no greater than 3.75 to 1.00, with certain alternative requirements for permitted acquisitions of at least $50.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a covenant requiring us to maintain an EBITDA to interest expense ratio for a period of four consecutive fiscal quarters as of the end of each quarter of no less than 3.00 to 1; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a covenant restricting us from paying dividends or repurchasing stock if, after giving effect to such payments and assuming no default exists or would result from such payment, our leverage ratio is greater than 2.50 to 1, in such case limiting such payments to the greater of 10% of consolidated total assets and $100.0 million during any fiscal year.

We were in compliance with the above financial covenants as of March 31, 2026.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

*Debt Outstanding*

Debt outstanding consisted of the following:

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Credit facility borrowings: |  |  |
| &nbsp;&nbsp;&nbsp;Revolving credit facility borrowings | $357.5 | $272.5 |
| Finance lease liabilities | 1.2 | 1.1 |
| Total debt | 358.7 | 273.6 |
| Less: current portion of long-term debt<sup>(a)</sup> | (0.4) | (0.4) |
| Long-term debt | $358.3 | $273.2 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)As of March 31, 2026, the Company was required to repay $0.4 million of finance lease liabilities over the next 12 months.

As of March 31, 2026, we had outstanding borrowings of $357.5 million under our revolving credit facility. We had letters of credit and bank guarantees outstanding in the amount of $3.2 million, leaving approximately $289.3 million of unused borrowing capacity on our revolving facility. Commitment fees on unused lines of credit for the three months ended March 31, 2026 were $0.1 million. The overall weighted average cost of debt was approximately 5.0% and net of related cross-currency swap instruments and fixed rate interest rate swap instruments was approximately 4.1%. Further details regarding the cross-currency swap instrument and fixed rate interest rate swap instrument are discussed in Note 10.

**9.&nbsp;&nbsp;&nbsp;&nbsp;Warranty**

We record a liability for warranty claims at the time of sale. The amount of the liability is based on the trend in the historical ratio of claims to sales, the historical length of time between the sale and resulting warranty claim, new product introductions and other factors. Warranty terms on machines generally range from one to four years. The majority of the liability for estimated warranty claims represents amounts to be paid out in the near term for qualified warranty issues.

The changes in warranty reserves were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Beginning balance | $9.7 | $10.5 |
| Additions charged to expense | 0.9 | 1.4 |
| Foreign currency fluctuations |  | 0.1 |
| Claims paid | (1.1) | (1.8) |
| Ending balance | $9.5 | $10.2 |

---

**10.&nbsp;&nbsp;&nbsp;&nbsp;Derivatives**

We report all derivative instruments as either assets or liabilities in our consolidated balance sheets at fair value. As a global organization, we are exposed to market risks, including fluctuations in foreign currency exchange rates and interest rates. To manage the volatility associated with these exposures, we enter into derivative instruments from time to time in accordance with our risk management policies.

We designate instruments as hedges on a transaction basis to support hedge accounting when the applicable criteria are met. The changes in fair value on these hedging instruments are intended to offset, in part or in whole, the corresponding changes in the fair value or cash flows of the underlying exposures being hedged.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

Gains and losses resulting from changes in fair value are accounted for based on the nature and use of the derivative and whether it is designed and qualifies for hedge accounting.

We assess hedge effectiveness at the inception of the hedging relationship and on an ongoing basis, both prospectively and retrospectively, in accordance with our policy. Any ineffective portion of a hedging instrument is recorded in the same line item of the consolidated statements of income as the item being hedged.

Our hedging policy also establishes maximum limits for each counterparty to reduce concentration of credit risk. We do not purchase, hold, or sell derivative financial instruments for trading purposes.

*Cash Flow Hedges*

The Company manages exposure to variability in cash flows related to its floating rate debt through the use of interest rate swaps. As of March 31, 2026, the Company had interest rate swaps with an aggregate notional amount of $120.0 million that effectively convert a portion of its variable rate debt to a fixed interest rate of 3.443%.

The interest rate swaps are designated as cash flow hedges under ASC 815. Changes in the fair value of the swaps, net of tax, are recorded in accumulated other comprehensive loss and are reclassified to interest expense, net, in the periods in which the hedged interest payments affect earnings. The swaps are scheduled to mature on October 1, 2029.

*Fair Value Hedges*

On April 5, 2022, we entered into Euro to U.S. dollar foreign exchange cross-currency swaps associated with an intercompany loan to a wholly owned European subsidiary. We enter into these foreign exchange cross-currency swaps to hedge the foreign currency risk associated with this intercompany loan, and accordingly, they are not speculative in nature. These cross-currency swaps are designated as fair value hedges.

As of March 31, 2026 and December 31, 2025, these cross-currency swaps included €75.0 million of total notional value. As of March 31, 2026, the aggregated scheduled interest payments over the course of the loan and related swaps amounted to €2.4 million. These swaps are scheduled to mature in April 2027.

*Net Investment Hedges*

On April 5, 2022, we entered into Euro to U.S. dollar foreign exchange cross-currency swaps to hedge our exposure to adverse foreign currency exchange rate movements between Tennant Company and its European subsidiaries. We enter into these fixed-to-fixed cross-currency swap agreements to protect a designated monetary amount of the Company's net investment in its Euro functional currency subsidiaries against the risk of changes in the Euro to U.S. dollar foreign exchange rate. These cross-currency swaps are designated as net investment hedges.

As of March 31, 2026 and December 31, 2025, the cross-currency swaps included €75.0 million of total notional value. These swaps are scheduled to mature in April 2027.

*Foreign Currency Forward Contracts Not Designated as Hedges*

We hedge our net recognized foreign currency denominated assets and liabilities with foreign currency forward contracts to reduce the risk that the value of these assets and liabilities will be adversely affected by changes in exchange rates. These contracts hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value as either assets or liabilities on the consolidated balance sheets with changes in the fair value recorded to net foreign currency transaction gain (loss) in our consolidated statements of income. These contracts do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged.

At March 31, 2026 and December 31, 2025, the notional amounts of foreign currency forward contracts outstanding not designated as hedging instruments were $85.5 million and $92.9 million, respectively.

<u>Balance Sheet Classification</u>

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

Derivatives are classified as either current or non-current assets or liabilities based on their anticipated settlement dates.

The following table summarizes the location and respective fair values of the Company's derivative financial instruments on a gross basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Other Current Assets** | **Other Current Liabilities** | **Other Assets** | **Other Liabilities** |
| **Derivatives designated as cash flow hedges:** | | | | |
| &nbsp;&nbsp;&nbsp;Interest rate swaps | $0.2 | $— | $0.1 | $— |
| **Derivatives designated as fair value hedges:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cross-currency swaps | 1.2 |  |  | 7.4 |
| **Derivatives designated as net investment hedges:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cross-currency swaps | 1.2 |  |  | 7.4 |
| **Derivatives not designated as hedging instruments:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts | 0.5 | 0.1 |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Other Current Assets** | **Other Current Liabilities** | **Other Assets** | **Other Liabilities** |
| **Derivatives designated as cash flow hedges:** | | | | |
| &nbsp;&nbsp;&nbsp;Interest rate swaps | $— | $— | $— | $0.4 |
| **Derivatives designated as fair value hedges:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cross-currency swaps | 1.2 |  |  | 8.9 |
| **Derivatives designated as net investment hedges:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cross-currency swaps | 1.2 |  |  | 8.9 |
| **Derivatives not designated as hedging instruments:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts | 0.3 | 0.1 |  |  |

---

The amount of the gains and losses on hedging instruments and the classification of those gains and losses within our consolidated financial statements for the three months ended March 31, 2026 were as follows:

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Gain (Loss) Recognized in Accumulated Other Comprehensive Loss, net of tax** | **Gain (Loss) Recognized in Accumulated Other Comprehensive Loss, net of tax** | **Gain (Loss) Reclassified into Income** | **Gain (Loss) Reclassified into Income** | |
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | |
| | **2026** | **2025** | **2026** | **2025** |<br>**Location of Gain (Loss) in Income Statement** |
| **Derivatives designated as cash flow hedges:** |  |  |  |  |  |
| &nbsp;&nbsp;Interest rate swaps | $0.6 | $(0.4) | $— | $0.1 | Interest Expense, Net |
| **Derivatives designated as fair value hedges:** |  |  |  |  |  |
| &nbsp;&nbsp;Cross-currency swaps | 0.3 | 0.7 | 0.2 | 0.3 | Interest Expense, Net |
| **Derivatives designated as net investment hedges:** |  |  |  |  |  |
| &nbsp;&nbsp;Cross-currency swaps | 1.4 | (1.9) | 0.2 | 0.2 | Interest Expense, Net |

---

The amount of gains and losses on derivative instruments not designated as hedging instruments and the classification of those gains and losses within our consolidated financial statements during the three months ended March 31, 2026 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Gain (Loss) Reclassified into Income** | **Gain (Loss) Reclassified into Income** | |
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | |
| | **2026** | **2025** |<br>**Location of Gain (Loss) in Income Statement** |
| **Derivatives not designated as hedging instruments:** |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts | $1.4 | $(2.5) | Net foreign currency transaction loss |

---

During the next twelve-month period, net (losses) gains expected to be reclassified into earnings are shown below:

---

| | |
|:---|:---|
| Interest rate swaps | $(0.1) |
| Cross-currency swaps | 1.2 |
| Total | $1.1 |

---

Such losses will be reclassified at the time that the underlying hedged transactions are realized.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**11.&nbsp;&nbsp;&nbsp;&nbsp;Fair Value Measurements**

**Financial Instruments**

The carrying amounts reported in the consolidated balance sheets for cash and cash equivalents, accounts receivable, other current assets, accounts payable and other current liabilities approximate fair value due to their short-term nature.

On February 21, 2024, the Company acquired certain investment securities in Brain Corp, a privately held autonomous technology company located in San Diego, California. The investment securities include $12.1 million of redeemable convertible preferred stock, $12.2 million of non-redeemable convertible preferred stock, and $7.8 million of warrants. The redeemable convertible preferred stock is accounted for as an available-for-sale debt security. The non-redeemable convertible preferred stock and warrants are accounted for as equity securities. All securities were recorded at their allocated fair value at the acquisition date.

In December 2025, the Company obtained the ability to exercise significant influence over Brain Corp and, as a result, adopted the equity method of accounting for its equity securities investment (see Note 12 – Equity Method Investments).

The available-for-sale debt security is carried at fair value with changes in fair value recognized in accumulated other comprehensive loss. The Company estimates fair value using Level 3 inputs.

As of March 31, 2026 and December 31, 2025, the cost and market values of our debt and equity securities were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Cost** | **Fair Value** | **Gross Unrealized Gains** | **Gross Unrealized Losses** |
| &nbsp;&nbsp;Balance as of March 31, 2026 |  |  |  |  |
| &nbsp;&nbsp;Available-for-sale debt securities | $12.1 | $11.8 | $— | $(0.3) |
| Total debt securities | $12.1 | $11.8 | $— | $(0.3) |
| &nbsp;&nbsp;Balance as of December 31, 2025 |  |  |  |  |
| &nbsp;&nbsp;Available-for-sale debt securities | $12.1 | $11.8 | $— | $(0.3) |
| Total debt securities | $12.1 | $11.8 | $— | $(0.3) |

---

The aggregate unrealized gains and losses on available-for-sale debt securities, net of tax effects, are classified in accumulated other comprehensive loss within shareholders' equity.

Scheduled maturities of our debt securities were as follows:

---

| | | |
|:---|:---|:---|
| | **Cost** | **Fair Value** |
| &nbsp;&nbsp;After 5 years through 10 years | $12.1 | $11.8 |
| Total debt securities | $12.1 | $11.8 |

---

**Fair Value Measurements and Financial Statement Presentation**

Estimates of fair value for financial assets and financial liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value and requires certain disclosures. The framework discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Unobservable inputs that reflect the reporting entity's own assumptions.

Our population of assets and liabilities subject to fair value measurements at March 31, 2026 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair<br>Value** | **Level 1** | **Level 2** | **Level 3** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;Debt securities | 11.8 |  |  | 11.8 |
| &nbsp;&nbsp;Foreign currency forward contracts | 0.5 |  | 0.5 |  |
| &nbsp;&nbsp;Cross-currency swaps | 2.4 |  | 2.4 |  |
| &nbsp;&nbsp;Interest rate swaps | 0.3 |  | 0.3 |  |
| Total assets | 15.0 |  | 3.2 | 11.8 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts | 0.1 |  | 0.1 |  |
| &nbsp;&nbsp;Cross-currency swaps | 14.8 |  | 14.8 |  |
| Total liabilities | $14.9 | $— | $14.9 | $— |

---

Our population of assets and liabilities subject to fair value measurements at December 31, 2025 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair<br>Value** | **Level 1** | **Level 2** | **Level 3** |
| Assets: |  |  |  |  |
| &nbsp;&nbsp;Debt securities | 11.8 |  |  | 11.8 |
| &nbsp;&nbsp;Foreign currency forward contracts | 0.3 |  | 0.3 |  |
| &nbsp;&nbsp;Cross-currency swaps | 2.4 |  | 2.4 |  |
| Total assets | 14.5 |  | 2.7 | 11.8 |
| Liabilities: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency forward contracts | 0.1 |  | 0.1 |  |
| &nbsp;&nbsp;Cross-currency swaps | 17.8 |  | 17.8 |  |
| &nbsp;&nbsp;Interest rate swaps | 0.4 |  | 0.4 |  |
| Total liabilities | $18.3 | $— | $18.3 | $— |

---

Our foreign currency forward contracts, cross-currency swaps and interest rate swaps are valued using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present value amount. Further details regarding our derivative instruments are discussed in Note 10.

There were no transfers into or out of Level 3 investments in the periods ended March 31, 2026 and December 31, 2025.

The fair value and carrying value of total debt, including current portion, was $370.6 million and $358.7 million, respectively, as of March 31, 2026. The fair value and carrying value of total debt, including current portion, was $281.4 million and $273.6 million, respectively, as of December 31, 2025. The fair value was estimated using

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

Level 3 inputs based on the borrowing rates currently available to us for bank loans with similar terms and remaining maturities.

**12. Equity Method Investments**

On February 21, 2024, the Company acquired certain investment securities of Brain Corp, as further described in Note 11 - Fair Value Measurements. The investment consists of $12.2 million of non-redeemable convertible preferred stock and $7.8 million of warrants to purchase common shares.

Prior to the vesting of all warrants on December 9, 2025, the Company accounted for the investment as an equity security under the measurement alternative. Upon vesting of the warrants, the Company's voting interest in Brain Corp increased to approximately 18% and its overall ownership interest increased to approximately 12%. Based on the voting interest, together with the board representation obtained in connection with the investment, the Company concluded that it has the ability to exercise significant influence over Brain Corp's operating and financial policies, but does not have controlling financial interest. Accordingly, beginning on December 9, 2025, the Company accounts for its investment in Brain Corp under the equity method of accounting.

Due to the timing and availability of Brain Corp's financial information, the Company recognizes its share of Brain Corp's earnings or losses on a three-month lag, based on the investee's most recently available financial statements. The Company did not recognize material equity method earnings/(losses) for the three months ended March 31, 2026.

As of March 31, 2026, the carrying amount of the Company's equity method investment in Brain Corp was $20.0 million and is included in Other Assets in the consolidated balance sheets.

**13.&nbsp;&nbsp;&nbsp;&nbsp;Commitments and Contingencies**

In the ordinary course of business, we are subject to the effects of certain contractual stipulations, events, transactions, and laws and regulations that may, at times, require the recognition of liabilities, such as those related to self-insurance estimated liabilities and claims, legal and contractual issues, environmental laws and regulations, guarantees, and indemnities. We establish estimated liabilities when the associated costs related to uncertainties or guarantees become probable and can be reasonably estimated.

*Oxygenator Water Techs vs. Tennant Company* 

The Company is a defendant in an intellectual property litigation matter with Oxygenator Water Technologies, Inc. (OWT) in the United States District Court for the District of Minnesota. In November 2024, a jury returned a verdict against the Company, and in September 2025, the Court issued a post-trial ruling enhancing damages. As of December 31, 2025 the Company has recorded a total accrued liability of approximately $20.5 million related to this matter.

In the first quarter of 2026, the Company recorded an incremental accrued expense and corresponding liability of $0.2 million based on updated estimates of interest costs.

The Company and OWT have appealed certain aspects of the Court's decisions. To stay execution of the judgment pending appeal, the Company has obtained a supersedeas bond in the amount of $20.3 million. The bond was issued by a third-party surety, and no cash collateral has been posted.

While the ultimate resolution of this matter is uncertain, management believes it has appropriately accrued for its current estimate of probable loss. The ruling does not restrict the Company's ability to sell its products and is not expected to impact its long-term business objectives.

*Other Matters*

Except as described above, there have been no material changes in the Company's estimated liabilities for self-insurance, litigation, environmental matters, guarantees, or indemnities, or in the related events and circumstances.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**14.&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' Equity**

*Accumulated Other Comprehensive Loss*

The changes in components of accumulated other comprehensive loss, net of tax, are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Foreign Currency <br>Translation <br>Adjustments** | **Pension and Post-<br>Retirement Medical <br>Benefits** | **Derivative Financial Instruments** | **Unrealized Loss on Debt Securities** | **Total** |
| Beginning balance | $(33.9) | $1.1 | $(0.1) | $(0.3) | $(33.2) |
| &nbsp;&nbsp;Other comprehensive (loss) income before reclassifications | (4.6) |  | 0.9 |  | (3.7) |
| &nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss | (0.2) |  | (0.2) |  | (0.4) |
| Net current period other comprehensive (loss) income | (4.8) |  | 0.7 |  | (4.1) |
| Ending balance | $(38.7) | $1.1 | $0.6 | $(0.3) | $(37.3) |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Foreign Currency** <br>**Translation** <br>**Adjustments** <sup>(1)</sup> | **Pension and Post-<br>Retirement Medical <br>Benefits** | **Derivative Financial Instruments** | **Unrealized Gain on Debt Securities** | **Total** |
| Beginning balance | $(75.2) | $2.8 | $(0.5) | $0.2 | $(72.7) |
| &nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 15.7 | (0.1) | 0.3 |  | 15.9 |
| &nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss | (0.2) |  | (0.4) |  | (0.6) |
| Net current period other comprehensive income (loss) | 15.5 | (0.1) | (0.1) |  | 15.3 |
| Ending balance | $(59.7) | $2.7 | $(0.6) | $0.2 | $(57.4) |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Includes foreign currency translation adjustments attributable to noncontrolling interests of $0.4 million.

**15.&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes**

We and our subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and foreign jurisdictions. We are generally no longer subject to U.S. federal tax examinations for taxable years before 2019. The number of years which remain open for audit for U.S. state or foreign tax purposes varies by jurisdiction but generally ranges from three to five years. We are currently undergoing income tax examinations in various foreign jurisdictions. Although the outcome of these examinations cannot be currently determined, we believe that we have adequate reserves with respect to these examinations.

We recognize potential accrued interest and penalties related to unrecognized tax benefits in income tax expense. In addition to the liability of $6.1 million for unrecognized tax benefits as of March 31, 2026, there was approximately $0.9 million for accrued interest and penalties. The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate as of March 31, 2026 was $5.5 million. To the extent interest and penalties are not assessed with respect to uncertain tax positions, amounts accrued will be revised and reflected as an adjustment of the income tax expense.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**16.&nbsp;&nbsp;&nbsp;&nbsp;Share-Based Compensation**

Our share-based compensation plans are described in Note 18 of our annual report on Form 10-K for the year ended December 31, 2025. During the three months ended March 31, 2026 and 2025, we recognized total share-based compensation expense of $1.5 million and $3.2 million, respectively. The total excess tax recognized for share-based compensation arrangements during the three months ended March 31, 2026 and 2025 was a tax expense of $0.4 million and a tax benefit of $0.2 million, respectively.

**17.&nbsp;&nbsp;&nbsp;&nbsp;Income Attributable to Tennant Company Per Share**

The computations of basic and diluted earnings per share were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| **Numerator:** |  |  |
| &nbsp;&nbsp;Net income | $0.2 | $13.1 |
| **Denominator:** |  |  |
| &nbsp;&nbsp;Basic - weighted average shares outstanding | 17558556 | 18702438 |
| &nbsp;&nbsp;Effect of dilutive securities | 246047 | 257569 |
| Diluted - weighted average shares outstanding | 17804603 | 18960007 |
| Basic earnings per share | $0.01 | $0.70 |
| Diluted earnings per share | $0.01 | $0.69 |

---

Excluded from the dilutive securities presented above were options to purchase and shares to be paid out under share-based compensation plans totaling 232,444 and 83,269 shares of common stock for the three months ended March 31, 2026 and 2025, respectively. These instruments were excluded when their exercise prices exceeded the average market price of our common stock for the period, when the number of shares we can repurchase under the treasury stock method exceeded the weighted average shares outstanding, or during periods of net loss, as their inclusion would have been anti-dilutive.

**18.&nbsp;&nbsp;&nbsp;&nbsp;Segment Reporting**

We are organized into four operating segments: North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. We combine our North America and Latin America operating segments into the "Americas" for reporting net sales by geographic area. In accordance with the objective and basic principles of the applicable accounting guidance, we aggregate our operating segments into one reportable segment that consists of the design, manufacture and sale of products used primarily in the maintenance of nonresidential surfaces.

The Company's chief operating decision maker ("CODM") is our chief executive officer. The CODM evaluates segment performance and makes resource allocation decisions using both net income and gross profit. Net income, which is also reported as consolidated net income on the consolidated statements of income, is regularly reviewed to assess segment performance. Additionally, the CODM uses gross profit to evaluate pricing and compare actual results to historical and forecasted data.

Significant expenses within net income include cost of sales, research and development, and selling and administrative expenses, which are each separately presented on the Company's consolidated statements of income. Other segment items within net income include net foreign currency transaction gain (loss), interest expense, net, other (expense) income, net, and income tax expense.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**19.&nbsp;&nbsp;&nbsp;&nbsp;Subsequent Event**

On April 29, 2026, the Board of Directors authorized a new share repurchase program under which the Company may repurchase up to 2,000,000 shares its our common stock through open market or privately negotiated transactions. This authorization is in addition to the approximately 560,000 shares remaining under the Company's existing share repurchase program. As a result, the Company has aggregate capacity to repurchase up to approximately 2,560,000 shares of its common stock.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**<u>Item 2.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Management's Discussion and Analysis of Financial Condition and Results of Operations</u>**

The following Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) provides a comparison of the Company's results of operations, as well as liquidity and capital resources for the quarters ended March 31, 2026 and 2025. The MD&A should be read in conjunction with the Company's consolidated financial statements and notes included in Item 1 of this Quarterly Report. Throughout this MD&A, the Company refers to measures used by management to evaluate performance, including financial measures that are not defined under generally accepted accounting principles (GAAP) in the U.S. Net sales excluding foreign currency translation (i.e., organic sales) is not a measure of financial performance under GAAP; however, the Company believes it is useful in understanding its financial results and provides comparable measures for understanding the operating results of the Company between different periods.

**Overview**

Tennant Company is a world leader in designing, manufacturing and marketing solutions that help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Our products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools and universities, hospitals and clinics, and more. Customers include contract cleaners to whom organizations outsource facilities maintenance as well as businesses that perform facilities maintenance themselves. The Company reaches these customers through the industry's largest direct sales and service organization and through a strong and well-supported network of authorized distributors worldwide.

**Macroeconomic Events**

As a global company, we are exposed to risks and uncertainties arising from macroeconomic, geopolitical, and regulatory conditions, including inflationary pressures, interest rate volatility, foreign currency fluctuations, changes in global capital markets, and evolving international trade and tariff policies. These factors continue to influence our operating environment and may impact revenue growth, margins, liquidity, and the execution of our strategic initiatives.

During the first quarter of 2026, macroeconomic conditions were affected by escalating geopolitical conflict involving Iran and heightened tensions in the Middle East, which disrupted global energy markets and transportation routes. As a result, global energy, fuel, and logistics costs increased, contributing to renewed inflationary pressures following periods of moderation in fiscal year 2025. These dynamics led to higher costs in certain areas of our cost structure, including freight and select raw materials, and could adversely affect customer demand if sustained.

We continue to implement cost management initiatives to mitigate these impacts and are actively monitoring supply chain, sourcing, and input cost trends, while continuing to evaluate the evolving macroeconomic environment and its potential impact on our business, financial condition, and results of operations.

As described in Part I, Item 1A - Risk Factors in the annual report on Form 10-K for the fiscal year ended December 31, 2025, we may encounter financial difficulties if the United States or other global economies experience an additional or continued long-term economic downturn as our product sales are sensitive to declines in capital spending by our customers. Any sustained adverse impacts to our business, the industries in which we operate, market demand for our products, and/or certain suppliers or customers may also affect our future results of operations, financial position, or cash flows. Changes in foreign currency may also adversely impact our new sales, earnings, and financial condition. We are actively monitoring the global macroeconomic environment, including geopolitical conflict, the potential impact of global supply chain constraints on material inflation, and change in demand for our products.

**Tariffs** 

On February 20, 2026, the United States Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act (IEEPA). The availability, timing, and amount

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

of any related refunds remain uncertain and subject to further legal and administrative processes. Following the decision, the U.S. presidential administration announced new temporary tariffs based on different statutory authority for a 150 day period beginning February 24, 2026. These actions have created continued uncertainty regarding tariff levels, duration, and the potential for additional actions or retaliatory measures, and we are monitoring developments to assess potential impacts on our business and results of operations.

**Outlook**

The Company entered fiscal year 2026 facing continued uncertainty in global economic conditions, elevated energy and logistics costs, and changes in international trade policy, including evolving U.S. tariff programs. Despite this environment, customer demand and order activity early in the year have remained favorable, supported by strength across core end markets and continued momentum in autonomous mobile robotics.

Operationally, fiscal year 2026 represents a transition period as the Company progresses beyond the initial implementation of its North America ERP system. ERP recovery advanced steadily during the first quarter, with operational performance improving meaningfully as the quarter progressed following a planned two-week shutdown of North American manufacturing facilities in January to complete a physical inventory count.

Management remains focused on restoring execution discipline and improving production flow, while continuing to actively manage inflationary pressures, including labor, freight, and tariffs. The Company continues to invest selectively in growth initiatives, including robotic and autonomous cleaning solutions, while maintaining a disciplined approach to spending, liquidity, and capital allocation.

**Results**

The following table compares the results of operations for the three months ended March 31, 2026 and 2025, respectively (in millions, except per share data and percentages):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **%** | **2025** | **%** |
| Net sales | $297.9 | 100.0 | $290.0 | 100.0 |
| Cost of sales | 184.3 | 61.9 | 170.0 | 58.6 |
| &nbsp;&nbsp;&nbsp;Gross profit | 113.6 | 38.1 | 120.0 | 41.4 |
| Selling and administrative expense | 98.1 | 32.9 | 90.7 | 31.3 |
| Research and development expense | 10.6 | 3.6 | 9.7 | 3.3 |
| &nbsp;&nbsp;&nbsp;Operating income | 4.9 | 1.6 | 19.6 | 6.8 |
| Interest expense, net | (3.4) | (1.1) | (2.3) | (0.8) |
| Net foreign currency transaction loss | (0.4) | (0.1) | (0.2) | (0.1) |
| Other (expense) income, net | (0.2) | (0.1) | 0.1 |  |
| &nbsp;&nbsp;&nbsp;Income before income taxes | 0.9 | 0.3 | 17.2 | 5.9 |
| Income tax expense | 0.7 | 0.2 | 4.1 | 1.4 |
| &nbsp;&nbsp;&nbsp;Net income | $0.2 | 0.1 | $13.1 | 4.5 |
| Net income per share - diluted | $0.01 |  | $0.69 |  |

---

**Net Sales**

Consolidated net sales for the first quarter of 2026 totaled $297.9 million, a 2.7% increase as compared to consolidated net sales of $290.0 million in the first quarter of 2025. The components of the consolidated net sales change were as follows:

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

---

| | |
|:---|:---|
| | **Three Months Ended March 31,** |
| | **2026 vs. 2025** |
| Price | 4.2% |
| Volume | (6.1)% |
| &nbsp;&nbsp;Organic decline | (1.9)% |
| Acquisitions | 0.5% |
| Foreign currency | 4.1% |
| &nbsp;&nbsp;Total | 2.7% |

---

The 2.7% increase in consolidated net sales in the first quarter of 2026 as compared to the same period in 2025 was driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A net favorable impact from foreign currency exchange of approximately 4.1% primarily due to the strengthening of the Euro, Brazilian real, and Mexican peso relative to the U.S. dollar; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Acquisition related growth of 0.5% driven by the acquisitions of distributors in EMEA; partly offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Organic sales decline of 1.9% primarily due to volume declines in North America related to ERP impacts earlier in the quarter, partly offset by pricing realization in North America and EMEA.

The following table sets forth the net sales by geographic area for the three months ended March 31, 2026 and 2025 (in millions, except percentages):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** | **% Change** |
| Americas | $194.0 | $197.3 | (1.7)% |
| Europe, Middle East and Africa | 86.9 | 76.0 | 14.3% |
| Asia Pacific | 17.0 | 16.7 | 1.8% |
| Total | $297.9 | $290.0 | 2.7% |

---

*Americas*

Americas net sales were $194.0 million for the first quarter of 2026, a decrease of 1.7% from the first quarter of 2025 driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Organic sales decline of 3.0% primarily driven by lower volumes in North America related to ERP impacts earlier in the quarter, partially offset by pricing realization in North America and increased rental and equipment volumes in Latin America; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A net favorable impact from foreign currency exchange of approximately 1.3%.

*Europe, Middle East and Africa ("EMEA")*

EMEA net sales were $86.9 million for the first quarter of 2026, an increase of 14.3% from the first quarter of 2025 driven by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A net favorable impact from foreign currency exchange of approximately 11.3%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Acquisition related growth of 2.0% driven by acquisitions of distributors; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Organic sales growth of 1.0% primarily due to price realization and equipment volume increases in France and Germany.

*Asia Pacific ("APAC")*

APAC net sales were $17.0 million for the first quarter of 2026, an increase of 1.8% from the first quarter of 2025 driven by:

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A net favorable impact from foreign currency exchange of approximately 3.8%; partly offset by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Organic sales decline of 2.0%, primarily driven by lower pricing in China equipment sales and softer underlying demand, particularly in China, Australia, and Southeast Asia, partially offset by volume growth in India and Korea.

**Gross Profit**

Gross profit margin of 38.1% was 330 basis points lower in the first quarter of 2026 compared to the first quarter of 2025. The margin rate decline was driven primarily by incremental labor, freight, and expediting costs associated with ERP recovery efforts earlier in the quarter, as well as a shift in customer mix toward strategic accounts, which carry a different margin profile. Tariff and other inflationary pressures were fully offset by price realization and cost-out initiatives.

**Operating Expense**

*Selling and Administrative Expense*

Selling and administrative expense ("S&A expense") was $98.1 million for the first quarter of 2026, an increase of $7.4 million compared to the first quarter of 2025. As a percentage of net sales, S&A expense for the first quarter of 2026 increased 160 basis points to 32.9% from 31.3% in the first quarter of 2025. The increase in S&A expense was primarily driven by unfavorable foreign currency, legal and financial advisory costs, higher compensation and benefits, and software subscription fees.

*Research and Development Expense*

Research and development expense ("R&D expense") was $10.6 million, or 3.6% of net sales, for the first quarter of 2026, with R&D expense as a percentage of net sales increasing 30 basis points compared to the first quarter of 2025.

We continue to invest in developing innovative products and technologies at levels necessary to propel our technology and innovative leadership position and drive growth.

**Total Other Expense, Net**

*Interest Expense, Net*

Interest expense, net was $3.4 million in the first quarter of 2026 compared to $2.3 million in the first quarter of 2025. The increase was the result of higher weighted average outstanding borrowings, including incremental borrowings to fund share repurchases, partly offset by a lower average interest rate. The following table compares the debt levels, average interest rate, interest income and interest expense for the three months ended March 31, 2026 and 2025, respectively (in millions, except percentages):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Weighted Average Outstanding Borrowings | $306.8 | $204.0 |
| Average interest rate | 5.0% | 5.7% |
| Interest expense | 4.4 | 3.2 |
| Interest income | (1.0) | (0.9) |
| Interest expense, net | $3.4 | $2.3 |

---

Our debt portfolio as of March 31, 2026 was comprised of debt predominately in U.S. dollars. The Company manages its floating rate debt exposure using fixed rate interest rate swaps to reduce the Company's risk of the possibility of increased interest costs. The Company has an aggregate $120.0 million notional amount of interest rate swaps that exchange a variable rate of interest for a fixed rate of interest of 3.44% over the term of the agreements.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

*Net Foreign Currency Transaction Loss*

Net foreign currency transaction loss was $0.4 million, a $0.2 million increase compared to the first quarter of 2025. The unfavorable impact was primarily due to volatile currency markets driving larger than normal exchange rate fluctuations on small unhedged exposures.

**Income Taxes**

The effective tax rate for the first quarter of 2026 was 80.5% compared to 23.8% for the first quarter of 2025. The increase was primarily due to an increase of discrete tax costs associated with share-based compensation as a percentage of pre-tax book income.

In general, it is our practice and intention to permanently reinvest the earnings of our foreign subsidiaries and repatriate earnings only when the tax impact is zero or immaterial. No deferred taxes have been provided for withholding taxes or other taxes that would result upon repatriation of our foreign investments to the U.S.

**Liquidity and Capital Resources**

*Liquidity*

Cash and cash equivalents totaled $82.6 million at March 31, 2026 compared to $106.4 million as of December 31, 2025. Wherever possible, cash management is centralized and intercompany financing is used to provide working capital to subsidiaries as needed. Our current ratio was 2.1 as of March 31, 2026 and 2.0 as of December 31, 2025. Our primary working capital, which is comprised of accounts receivable, inventories and accounts payables, was $362.1 million as of March 31, 2026 and $327.8 million as of December 31, 2025. Our debt-to-capital ratio was 40.2% as of March 31, 2026 compared to 31.2% as of December 31, 2025.

As of March 31, 2026, we had letters of credit and bank guarantees outstanding in the amount of $3.2 million, leaving approximately $289.3 million of unused borrowing capacity on our revolving facility.

*Cash Flow from Operating Activities*

Net cash used in operating activities during the three months ended March 31, 2026 was $31.2 million compared to net cash used in operating activities of $0.4 million during the three months ended March 31, 2025. The increase was the result of investments in working capital investments, reflecting increases in accounts receivable and inventory, lower accounts payable, and changes in other assets and liabilities, as well as lower operating performance.

*Cash Flow from Investing Activities*

Net cash used in investing activities during the three months ended March 31, 2026 was $10.3 million compared to net cash used in investing activities of $6.9 million during the three months ended March 31, 2025. The increase was primarily due to the acquisition of Clean Machine in the first quarter of 2026, partly offset by lower capital expenditures.

*Cash Flow from Financing Activities*

Net cash provided by financing activities during the three months ended March 31, 2026 was $17.2 million compared to net cash used in financing activities of $13.7 million during the three months ended March 31, 2025. The increase was driven by increased net proceeds from borrowing, partly offset by higher repurchases of common stock.

**Newly Issued Accounting Guidance**

See Note 2 to the consolidated financial statements for information on new accounting pronouncements.

In October 2023, the FASB issued ASU 2023-06 *Disclosure Improvements: Codification Amendments* in Response to the SEC's Disclosure Update and Simplification Initiative, which aims to clarify or improve disclosure and presentation requirements on a variety of topics and align the requirements in the FASB accounting standard with the Securities and Exchange Commission regulations. This guidance is effective for

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

the Company no later than June 30, 2027. We do not expect the amendments in this update to have a material impact on our consolidated financial statements.

In November 2024, the FASB issued ASU 2024-03 *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220) - Disaggregation of Income Statement Expenses*, which requires disaggregation of certain income statement expense captions into specified categories to be disclosed within the notes to the financial statements, but does not change the expense captions on the consolidated income statement. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to consolidated financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the consolidated financial statements. We are evaluating the effect that this guidance will have on our consolidated financial statements and related disclosures.

In November 2025, the FASB issued ASU 2025-09 Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, which includes amendments to more closely align hedge accounting with the economics of an entity's risk management activities. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within those fiscal years. Early adoption is permitted. The amendments should be applied on a prospective basis. We are evaluating the impact of the ASU to determine its impact on our consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-11 Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the applicability of the interim reporting guidance, the types of interim reporting, and the form and content of interim financial statements in accordance with U.S. generally accepted accounting principles. The amendment does not intend to change the fundamental nature of interim reporting or expand or reduce current interim reporting disclosure requirements, but rather aims to provide clarity and improve navigability of the existing interim reporting requirements. The update will be effective for interim periods within annual periods beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively or retrospectively to any or all prior periods presented in the financial statements. We are evaluating the impact of the ASU to determine its impact on our consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-12 Codification Improvements, which aims to update the FASB Accounting Standards Codification for a broad range of topics arising from technical corrections, unintended application or the Codification, clarifications, and other minor improvements. The ASU is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years. We are evaluating the effect that this guidance will have on our consolidated financial statements and related disclosures.

No other new accounting pronouncements issued but not yet effective have had, or are expected to have, a material impact on our results of operations or financial position.

**Cautionary Statement Relevant to Forward-Looking Information**

This Quarterly Report, including "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Item 2, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "project," or "continue" or similar words or the negative thereof. These statements do not relate to strictly historical or current facts and provide current expectations or forecasts of future events. Any such expectations or forecasts of future events are subject to a variety of factors. These include factors that affect all businesses operating in a global market as well as matters specific to us and the markets the Company serves. Particular risks and uncertainties presently facing us include: geopolitical and economic uncertainty throughout the world; our ability to comply with global laws and regulations; changes in foreign currency exchange rates; our ability to adapt to customer pricing sensitivities; the competition in our business; fluctuations in the cost, quality or availability of raw materials and purchased components; our ability to adjust pricing to respond to cost pressures; unforeseen product liability claims or product quality issues; our ability to attract, retain and develop key personnel and create effective succession planning strategies; our ability to effectively develop and manage strategic planning and growth processes and the related operational plans; our ability to successfully upgrade and evolve our information technology systems; our ability to successfully protect our information technology systems from cybersecurity risks; complications with our new ERP system; the occurrence of a significant business interruption; our ability to maintain the health and safety of our workers; our ability to integrate acquisitions; our

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

ability to develop and commercialize new innovative products and services; and risks related to our business transformation and strategic initiatives.

We caution that forward-looking statements must be considered carefully and that actual results may differ in material ways due to risks and uncertainties both known and unknown. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Additional information about factors that could materially affect our results can be found in Part I, Item 1A, Risk Factors in our annual report on Form 10-K for the year ended December 31, 2025.

We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Investors are advised to consult any further disclosures by us in our filings with the SEC and in other written statements on related subjects. It is not possible to anticipate or foresee all risk factors, and investors should not consider any list of such factors to be an exhaustive or complete list of all risks or uncertainties.

**<u>Item 3.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Quantitative and Qualitative Disclosures About Market Risk</u>**

There have been no material changes in our market risk since December 31, 2025. For additional information, refer to Item 7A of our annual report on Form 10-K for the year ended December 31, 2025.

**<u>Item 4.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Controls and Procedures</u>**

*Disclosure Controls and Procedures*

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2026 (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive and our principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.

*Changes in Internal Controls*

There were no changes in our internal control over financial reporting during the fiscal quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II** – **OTHER INFORMATION**

**<u>Item 1.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Proceedings</u>**

Refer to Note 17, *Commitments and Contingencies*, to the Consolidated Financial Statements in the Company's Form 10-K for information regarding the Company's legal proceedings. There have been no material developments in any legal proceedings that require reporting in this Form 10-Q.

**<u>Item 1A.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Risk Factors</u>**

We documented our risk factors in Item 1A of Part I of our annual report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our risk factors since the filing of that report.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**<u>Item 2.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>**

Share repurchases are made from time to time in the open market or through privately negotiated transactions. On February 11, 2025, the Board of Directors authorized the repurchase of 2,000,000 shares of our common stock. Under the share repurchase program, 564,293 shares remain authorized.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **For the Quarter Ended<br>March 31, 2026** | **Total Number of Shares**<br>**Purchased**<sup>(1)</sup> | **Average Price Paid**<br>**Per Share**<sup>(2)</sup> | **Total Number of Shares Purchased as Part of<br>Publicly Announced Plans or<br>Programs** | **Maximum Number of Shares that May Yet Be<br>Purchased Under the Plans or<br>Programs** |
| January 1-31, 2026 |  | $— |  | 1514063 |
| February 1-28, 2026 | 98594 | $62.13 | 52000 | 1462063 |
| March 1-31, 2026 | 897822 | $63.22 | 897770 | 564293 |
| Total | 996416 | $63.11 | 949770 | 564293 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The total number of shares purchased includes 46,646 shares withheld to cover withholding taxes related to the exercise of stock options and the vesting of restricted stock under employee share-based compensation plans.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The Inflation Reduction Act of 2022, which was enacted into law on August 16, 2022, imposes a nondeductible 1% excise tax on the net value of certain stock repurchases made after December 31, 2022. During the three months ended March 31, 2026, the Company reflected the applicable excise tax in treasury stock as part of the cost basis of the stock repurchased and recorded a corresponding liability for the excise taxes payable in other current liabilities on the consolidated balance sheets. All dollar amounts presented exclude such excise taxes.

**<u>Item 5.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Information</u>**

On March 3, 2026, Donal L. Mulligan, a member of the Board of Directors, terminated a Rule 10b5-1 trading arrangement that had been adopted on March 6, 2024 and provided for the sale of up to 3,538 shares of the Company's common stock until April 28, 2026.

During the three months ended March 31, 2026, no other director or officer of the Company adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**<u>Item 6.</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>Exhibits</u>**

---

| | | |
|:---|:---|:---|
| **Item #** | **Description** | **Method of Filing** |
| 3.1 | <u>[Restated Articles of Incorporation](https://www.sec.gov/Archives/edgar/data/97134/000089710106001609/tennant062974_ex3i.htm)</u> | Incorporated by reference to Exhibit 3i to the Company's report on Form 10-Q for the quarterly period ended June 30, 2006. |
| 3.2 | <u>[Amended and Restated By-Laws](https://www.sec.gov/Archives/edgar/data/97134/000110465923005013/tm233790d1_ex3-2.htm)</u> | Incorporated by reference to Exhibit 3.2 to the Company's Form 8-K dated January 19, 2023. |
| 3.3 | <u>[Articles of Amendment of Restated Articles of Incorporation of Tennant Company](https://www.sec.gov/Archives/edgar/data/97134/000009713418000015/exhibit3iii.htm)</u> | Incorporated by reference to Exhibit 3iii to the Company's report on Form 10-Q for the quarterly period ended March 31, 2018. |
| 10.1 | <u>[Cooperation Agreement, dated as of February 12, 2026, by and among Tennant Company, Vision One Fund, LP, and certain of its affiliates listed on the signature pages thereto](https://www.sec.gov/Archives/edgar/data/97134/000110465926015182/tm266208d1_ex10-1.htm)</u> | Incorporated by reference to Exhibit 10.1 to the Company's 8-K dated February 13, 2026. |
| 31.1 | <u>[Rule 13a-14(a)/15d-14(a) Certification of CEO](tnc-20260331xexx311.htm)</u> | Filed herewith electronically. |
| 31.2 | <u>[Rule 13a-14(a)/15d-14(a) Certification of CFO](tnc-20260331xexx312.htm)</u> | Filed herewith electronically. |
| 32.1 | <u>[Section 1350 Certification of CEO](tnc-20260331xexx321.htm)</u> | Filed herewith electronically. |
| 32.2 | <u>[Section 1350 Certification of CFO](tnc-20260331xexx322.htm)</u> | Filed herewith electronically. |
| 101 | The following financial information from Tennant Company's Quarterly Report on Form 10-Q for the period ended March 31, 2026, formatted in Inline eXtensible Business Reporting Language (iXBRL): (i) Consolidated Statements of Income for the three months ended March 31, 2026 and 2025; (ii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and 2025; (iii) Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025; (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2025; (v) Consolidated Statements of Equity for the three months ended March 31, 2026 and 2025; and (vi) Notes to the Consolidated Financial Statements | Filed herewith electronically. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | Filed herewith electronically. |

---

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | TENNANT COMPANY |
| Date: | May 5, 2026 | /s/ Fay West |
| | | Fay West<br>Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |

---

------

<u>[**Table of Contents**](#i76015f54ee1c44899f4366fa9362c473_7)</u>

HIDDEN IXBRL

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS**

I, David W. Huml, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Tennant Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | May 5, 2026 | /s/ David W. Huml |
| | | David W. Huml<br>President and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATIONS**

I, Fay West, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Tennant Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: | May 5, 2026 | /s/ Fay West |
| | | Fay West<br>Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report of Tennant Company (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David W. Huml, President and Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | May 5, 2026 | /s/ David W. Huml |
| | | David W. Huml<br>President and Chief Executive Officer |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the quarterly report of Tennant Company (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Fay West, Senior Vice President and Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | May 5, 2026 | /s/ Fay West |
| | | Fay West<br>Senior Vice President and Chief Financial Officer |

---

<br>